Davita Inc vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? Davita Inc trades at $178.63 (market cap $11.38B), while Direxion Daily Semiconductor Bull 3X Shares trades at $145. The key difference: Davita Inc is trading nearer its 52-week high, Direxion Daily Semiconductor Bull 3X Shares nearer its low. Which is the better fit depends on your goals.
| DVA | SOXL | |
|---|---|---|
Market Cap | $11.38B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $240.96 | $300.77 |
52-Week Low | $103.87 | $24.91 |
Enterprise Value | $24.10B | — |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.69, down slightly by 0.04% over the past day. The stock shows strong fundamental performance with consistent earnings beats in recent quarters, including Q2 2026 EPS of $4.02 versus $3.88 expected (Zacks Investment Research, 2026-08-04). However, technical indicators signal a bearish trend, with the price near key support at $182. Revenue growth remains steady, climbing to $13.64 billion in 2025, though net income margin dipped to 5.47%.
The outlook is mixed; analyst consensus leans bullish with a $232.25 price target (MarketBeat, 2026-08-05), but risks include reimbursement pressure and high debt levels. Investment appeal hinges on execution against guidance amid payer-mix challenges, with the current valuation offering potential upside if operational trends stabilize.
SOXL, the Direxion Daily Semiconductor Bull 3X ETF, trades at $146.05 after a significant 12.35% daily gain, though technical indicators remain bearish overall with moving averages signaling caution. The leveraged ETF has experienced extreme volatility, gaining over 500% in early 2026 before declining more than 60% from recent peaks. Recent semiconductor sector news shows mixed sentiment with government support initiatives but concerns about China's AI export controls and investor rotation out of chip stocks.
As a 3x leveraged ETF, SOXL offers amplified exposure to semiconductor sector movements but carries substantial decay and volatility risks. The current bearish technical setup suggests continued pressure, while fundamental semiconductor demand remains strong due to AI-driven growth. Investors should be aware that leveraged ETFs are designed for short-term trading and may not track long-term semiconductor industry performance accurately.
Trailing returns across standard periods
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →